Corrigendum: “Nomogram Predicting Bladder Cancer–specific Mortality After Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-invasive Bladder Cancer: Results of an International Consortium” (European Urology Focus (2021) 7(6) (1347–1354), (S240545692030208X), (10.1016/j.euf.2020.07.002))

Maria Carmen Mir, Michele Marchioni, Homi Zargar, K. Zargar-Shoshtari, A. S. Fairey, Laura S. Mertens, C. P. Dinney, L. M. Krabbe, M. S. Cookson, N. E. Jacobsen, J. Griffin, J. S. Montgomery, N. Vasdev, E. Y. Yu, E. Xylinas, J. S. McGrath, W. Kassouf, M. A. Dall'Era, S. S. Sridhar, J. AningS. F. Shariat, J. L. Wright, A. C. Thorpe, T. M. Morgan, J. M. Holzbeierlein, T. J. Bivalacqua, S. North, D. A. Barocas, Y. Lotan, P. Grivas, A. J. Stephenson, J. B. Shah, B. W. van Rhijn, P. E. Spiess, S. Daneshmand, P. C. Black

Research output: Contribution to journalComment/debatepeer-review

Fingerprint

Dive into the research topics of 'Corrigendum: “Nomogram Predicting Bladder Cancer–specific Mortality After Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-invasive Bladder Cancer: Results of an International Consortium” (European Urology Focus (2021) 7(6) (1347–1354), (S240545692030208X), (10.1016/j.euf.2020.07.002))'. Together they form a unique fingerprint.

Medicine & Life Sciences